Because of significantly different protein expression in benign prostate hyperplasia compared with normal and tumor prostate tissues, CSN1S1 has been reported as a potential biomarker for early identification of benign prostate hyperplasia patients43. This evidence concerns the gene CSN1S1 and benign prostatic hyperplasia.